Ontology highlight
ABSTRACT: Background
Mutations in the BRCA1 and BRCA2 genes are responsible for only a part of hereditary breast cancer (HBC). The origins of "non-BRCA" HBC in families may be attributed in part to rare mutations in genes conferring moderate risk, such as CHEK2, which encodes for an upstream regulator of BRCA1. Previous studies have demonstrated an association between CHEK2 founder mutations and non-BRCA HBC. However, very few data on the entire coding sequence of this gene are available.Methods
We investigated the contribution of CHEK2 mutations to non-BRCA HBC by direct sequencing of its whole coding sequence in 507 non-BRCA HBC cases and 513 controls.Results
We observed 16 mutations in cases and 4 in controls, including 9 missense variants of uncertain consequence. Using b
SUBMITTER: Desrichard A
PROVIDER: S-EPMC3326561 | biostudies-literature | 2011
REPOSITORIES: biostudies-literature